Key Secondary Endpoint: Percent Change in BMI From Baseline at 30 Weeks<sup>1,2</sup>

Accordion title open

Show Description

Accordion title close

Close Description

Key Secondary Endpoint: Percent Change in BMI From Baseline at 30 Weeks^1,2

A bar chart showing the percent change in BMI from baseline for Mounjaro vs placebo. The mean baseline BMI was 35 kilograms per square meter. Mounjaro 5 mg (n=32) had a 6.9% reduction from baseline; Mounjaro 10 mg (n=33) had a 10.8% reduction from baseline; pooled Mounjaro (5 mg and 10 mg) (n=65) had a 8.8% reduction from baseline; and placebo (n=34) had a 0.5% reduction from baseline.

Key Secondary Endpoint: Percent Change in BMI From Baseline at 30 Weeks1,2

Key Secondary Endpoint: Percent Change in BMI From Baseline at 30 Weeks^1,2